—ITW
— • —
$270.52
P/E
25.78
PEG
—
FCF Yield
—
Rev Growth YoY
+92.0% YoY
Gross Margin
4410.0%
Health Score
4/10
D/E Ratio
2.78
Confidence
LOW
Business Snapshot
The ticker and exchange information are absent from this data payload, which limits full company identification. Based on the available financial profile — a current price of $270.52, a Price/Sales ratio of 4.87x, and gross margins exceeding 4,000% — this appears to be a highly asset-light or financial-services-adjacent business. Without a confirmed market capitalisation figure, cap tier classification cannot be made with certainty, though the valuation ratios suggest a meaningful-sized enterprise.
Financial Health
Score: 4/10
The financial picture here is deeply contradictory. On one hand, gross margins of 4,410% and a net margin of 1,911% (TTM) are extraordinary on their face, suggesting either a highly unusual business model or potential data anomalies that warrant scrutiny...
Risk Assessment
- DATA INTEGRITY: Gross margin of 4,410% and net margin of 1,911% are statistically implausible for most business models and may indicate data errors or an extremely unusual financial structure that warrants independent verification.
- EARNINGS DETERIORATION: Earnings growth of -1,044% YoY means profitability collapsed sharply even as revenue nearly doubled — a major red flag for operating leverage and cost control.
- DEBT: Debt/Equity of 2.78x signals high financial leverage, amplifying downside risk in any revenue or margin compression scenario.
- ANALYST CONSENSUS: Only 8% of covering analysts rate the stock a Buy, with 50% at Hold and the consensus formally at Sell — a notably weak endorsement from Wall Street professionals.
- TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) alongside a bearish MACD signal indicates deteriorating price momentum.
---...
**Score: 4/10** The financial picture here is deeply contradictory. On one hand, gross margins of 4,410% and a net margin of 1,911% (TTM) are extraordinary on their face, suggesting either a highly unusual business model or potential data anomalies that warrant scrutiny. Against this, the balance sheet carries significant leverage with a Debt/Equity ratio of 2.78x, indicating the company is heavily financed by borrowing. Free cash flow data is entirely absent, making it impossible to verify whether these headline margins translate into actual cash generation — a critical gap for any financial health assessment. ---
- **DATA INTEGRITY:** Gross margin of 4,410% and net margin of 1,911% are statistically implausible for most business models and may indicate data errors or an extremely unusual financial structure that warrants independent verification. - **EARNINGS DETERIORATION:** Earnings growth of -1,044% YoY means profitability collapsed sharply even as revenue nearly doubled — a major red flag for operating leverage and cost control. - **DEBT:** Debt/Equity of 2.78x signals high financial leverage, amplifying downside risk in any revenue or margin compression scenario. - **ANALYST CONSENSUS:** Only 8% of covering analysts rate the stock a Buy, with 50% at Hold and the consensus formally at Sell — a notably weak endorsement from Wall Street professionals. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below 200-day MA) alongside a bearish MACD signal indicates deteriorating price momentum. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives